Abstract
Scleromyxedema is a rare dermatological disorder marked by widespread symmetric 2- to 3-mm, firm, waxy, closely spaced papules involving the hands, forearms, face, neck, upper trunk and thighs. The most common extracutaneous manifestation of scleromyxedema is a benign plasma cell dyscrasia. Treatment of scleromyxedema is limited by the lack of long-term results, toxicity and significant adverse side effects. We report a severe case of scleromyxedema who had marked improvement when treated with thalidomide. Copyright © 2006 S. Karger AG.
| Original language | English |
|---|---|
| Pages (from-to) | 150-152 |
| Number of pages | 3 |
| Journal | Dermatology |
| Volume | 213 |
| Issue number | 2 |
| DOIs | |
| State | Published - Aug 2006 |
| Externally published | Yes |
ASJC Scopus Subject Areas
- Dermatology
Keywords
- Immunosuppressives
- Scleromyxedema
- Thalidomide
- Severity of Illness Index
- Thalidomide/therapeutic use
- Follow-Up Studies
- Paraproteins/drug effects
- Humans
- Middle Aged
- Scleromyxedema/blood
- Angiogenesis Inhibitors/therapeutic use
- Female
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS